Breaking News

Canadian Researchers Find Carbon Nanotech and Thulium in Moderna and Pfizer Covid Injections

Print Friendly, PDF & Email

After reviewing electron microscope images of elements contained in the Covid Pfizer and Moderna injections, Dr. Daniel Nagase revealed that, strangely, the contents of the Pfizer and Moderna “vaccines” show no signs of biological material, including mRNA or DNA.

Dr. Nagase is a Canadian emergency room doctor who was put on involuntary leave for successfully treating Covid patients with ivermectin in a central-Alberta hospital in 2021.  He has since been touring through Alberta and British Columbia (“BC”) speaking at rallies on treatment options for Covid. Nagase said he has also been “learning a lot about the legal system” while reviewing the medical records of people whose family members believe have died as a result of the “vaccines.”

In the video below Dr. Nagase discusses his findings with Melanie Risdon, a reporter with the Western Standard.


Let’s not lose touch…Your Government and Big Tech are actively trying to censor the information reported by The Exposé to serve their own needs. Subscribe now to make sure you receive the latest uncensored news in your inbox…


Follow The Exposé’s Official Channel on Telegram here
Join the conversation in our Telegram Discussion Group here


Dr. Nagase was able to obtain samples of both Pfizer and Moderna Covid injections.  “Unfortunately, both these samples had to travel for an extensive period of time in various vehicles. So, they’ve been unrefrigerated for up to two months. I don’t know exactly how long they’ve been left unrefrigerated,” he said.

Initially, the research group looked at these Moderna and Pfizer samples under a regular microscope. Although there were a lot of very interesting images, they were unable to be conclusive about what exactly they were seeing. So, they used an electron microscope to determine what elements the “vaccines” contained.

“You would expect to see carbon, oxygen, nitrogen, and phosphorus – all the things you would normally see in a protein,” he said.  The team of researchers found carbon and oxygen but none of the samples contained nitrogen or phosphorous.

“X-ray spectroscopy didn’t detect any nitrogen or phosphorus. So, if those complex shapes – that rectangle with all the dots arranged in a grid – were the result of some kind of biological process … then there should be nitrogen and phosphorus there in addition to carbon and oxygen. Because every living thing, whether it’s a virus, plant or animal, is made up of proteins that contain nitrogen, carbon, oxygen, and phosphorus.”

And electron microscopy revealed the same, no nitrogen and no phosphorous.

“[This] particular Moderna sample from somewhere in Canada has no RNA in it. It has no mRNA. Or if there was mRNA in it, somehow it disappeared after being left unrefrigerated for anywhere from one to two months,” he said.

Dr.  Nagase examined a “ball with the legs growing out of it” found inside a Moderna sample. “This shape, this ball with the legs growing out of it, for some reason has aluminium in it. And I can say with certainty that this isn’t a mould spore or some other type of biological contamination, because the only thing in it is carbon, oxygen, and no signs of nitrogen, no signs of phosphorus, which would indicate something biological of origin. So, this thing that’s growing is non-biological.”

Found in a Moderna Covid “vaccine” sample

This confirms what Polish biologist and geologist Dr. Franc Zalewksi discovered last year about what he called a “something” or a “thing” and was later called a “nano-octopus” by La Quinta Columna.

“It seems to have one head and three legs. I did some tests and here are the results: aluminium, bromine and carbon,” Dr. Zalewski said. He established that the head of the “thing” was made of aluminium.

A surprising and new discovery that Dr. Nagase and the researchers made was an unusual element from the lanthanide series – thulium – in a fibre-like structure found in a Pfizer sample.

Found in a Pfizer Covid “vaccine” sample

According to Wikipedia, as edited 20 April 2022, “thulium is the second-least abundant of the lanthanides … It is an easily workable metal with a bright silvery-grey lustre. It is fairly soft and slowly tarnishes in air. Despite its high price and rarity, thulium is used as the radiation source in portable X-ray devices, and in some solid-state lasers. It has no significant biological role and is not particularly toxic … it is never found in nature in pure form, but it is found in small quantities in minerals with other rare earths … The principal sources today are the ion adsorption clays of southern China.”

Dr. Nagase and the researchers found a variety of shapes and structures inside the “vaccine” samples they tested – crystals, chips, strands, bulbs, spheres, fibres and balls with legs growing out of them – “we have polymorphic, which is many different forms,” he said.

“They all seem to be made predominantly out of carbon and oxygen and they were in both the Moderna and Pfizer samples, and they seem to be in fibre forms. In the Moderna sample, the carbon-oxygen structures seem to be taking nanosphere forms and crystalline forms. And in the Pfizer sample … seem to only be forming fibres and crystals.

“So again, what are all these things doing? Carbon-oxygen can certainly be a sign that there’s graphene in it but how do they make graphene take all these different shapes: from spheres to fibres to crystals, this is a technology that I am not aware of with my scientific knowledge.

“I don’t even know if this carbon technology, this carbon nanotechnology is in every batch or is it just in the batches they sent to Canada? Is Canada one half of an experiment and certain States in the US are getting a slightly different batch without the carbon nanotech? And then are countries around the world being given different injections, and we’re being observed to see, ‘well, who dies the fastest, who gets the sickest or what kind of illnesses result’ from experimental ingredients being indiscriminately and without disclosure being given to people?”

Click on the image below to watch Dr, Nagase’s presentation on Rumble.

Western Standard: Dr. Nagase reviews images from Covid vaccines, shows no ‘elements of life’, 18 April 2022 (46 mins)

The transcript of Dr. Nagase’s presentation, including images of his slides, is attached below.

Share this page to Telegram

Categories: Breaking News, World News

Tagged as:

4.3 6 votes
Article Rating
Subscribe
Notify of
guest
56 Comments
Inline Feedbacks
View all comments
Marty Pops
Marty Pops
2 months ago

Dr. Carrie Madej also found this way back last year. It is nothing new but interesting to see that a Canadian researcher got in it.

Daisy Beagle
Daisy Beagle
2 months ago

It is not from a lack of trying of that I am certain but it still frustrates me to think that these so called vaccines contain many horrible things that are detrimental to health and nobody is able to confront the manufacturers with the evidence. To get Bourla in a room and to ask him what the hell these nanoparticles etc are doing in his vaccines is unlikely to happen for the time being anyway. And then we have Bill Gates in one breath boasting that vaccines gives him 20x return in his investment and in the next he pretends that he is hurt and upset because people hate him when all he is doing is trying to save lives ! I believe there will be a reckoning but we will have to be patient until that time comes.

Sherry
Sherry
Reply to  Daisy Beagle
2 months ago

hi

Tonia
Tonia
Reply to  Daisy Beagle
2 months ago

The only reckoning will be when Jesus returns. They have infiltrated too deeply now. There is no one left to on the side of justice to persecute them. We are in the end days. It will happen just like Revelations says.

Islander
Islander
Reply to  Tonia
2 months ago

Yea and amen!
And, behold, I come quickly; and My reward is with Me, to give every man according as his work. Revelation 22:12.
And what ‘reward’ will the murderers get!

lucy
lucy
2 months ago

Looks to me like a distraction technique to try to convince people that these jabs do not change your DNA. They DO. They are the Mark of the Beast. Period.

GundelP
GundelP
Reply to  lucy
2 months ago

Prove it!
Besides even radiation changes your DNA, after Chernobyl many babies born dead and with malformations. Graphene oxide (in the shots) multiplies environmental radiation (wireless tech) with 1000x.

Tonia
Tonia
Reply to  GundelP
2 months ago

Ha ha ha. She needs to prove nothing. If you haven’t been given discernment from God & given eyes to see & ears to hear then that is no ones fault but your own.
It is the mark. And those that took it, names are not in the book of life. You will fiind out the hard way.

Tonia
Tonia
Reply to  lucy
2 months ago

Yes i agree Lucy. It is the mark of the beast. After the sgot you are genetically modified & therefore no longer born in the image of God. The patent number on the jab contains the number 666 & once injected you are owned by the patent owner. The Luciferace gel derived from a Jellyfish illuminates under a black light, hence why there are purple street lights popping up everywhere. They will have cameras in them which gives those who serve the beast the ability to see who has been jabbed & who hasn’t.

Brad
Brad
Reply to  Tonia
2 months ago

I too have heard about the change of street light colours. I heard it was so that the Greys can see more easily as their big black eyes are actually a black lens covering, to shield them from our light. The new colour therefore helped them, but I shall consider your input too.

Tonia
Tonia
Reply to  lucy
2 months ago

I forgot to add that;
Also the supreme court in America has ruled that anything genetically modified forfeits its God given inalienable rights.
That ruling is apparently worldwide.

Tighe
Tighe
2 months ago

It seems a great shame not to have used fresh samples that had not possibly degraded, especially if they were not kept at the right temperatures. Is it really that difficult to get samples of these vaccines?

GundelP
GundelP
2 months ago

Hehe. I told you so. Spike protein was a diversion all along. Magnetic protein?!
Carbon and oxygen – graphene oxide.

Tonia
Tonia
2 months ago

Anyone can go to their local shopping centre or even cemetery and turn on their blue tooth & scan new devices & you’ll see the jabbed are hooked up to the internet via black goo aka graphene oxide. Australia’s federal health minister Greg Hunts (i like to change the H to a C personally)
Brother is a scientists and has his own laboratory where for the past 15 years has been experimenting with graphene oxide on mice & is able to control them via remote control.
Think about that for a minute.
Smart metres on everyone’s homes spells disaster.
All works of the antichrist.

trackback
2 months ago

[…] Source: Canadian Researchers Find Carbon Nanotech and Thulium in Moderna and Pfizer Covid Injections […]

trackback
2 months ago

[…] Canadian Researchers Find Carbon Nanotech and Thulium in Moderna and Pfizer Covid Injections: https://expose-news.com/2022/05/27/carbon-nanotech-and-thulium-in-covid-injections/ […]

trackback
2 months ago

[…] Canadian Researchers Find Carbon Nanotech and Thulium in Moderna and Pfizer Covid Injections After reviewing electron microscope images of elements contained in the Covid Pfizer and Moderna injections, Dr. Daniel Nagase revealed that, strangely, the contents of the Pfizer and Moderna “vaccines” show no signs of biological material, including mRNA or DNA. […]

Fleur
Fleur
2 months ago

Pfizer side effects see pages 30 to 38

5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021

APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST 1p36 deletion syndrome;2-Hydroxyglutaric aciduria;5’nucleotidase increased;Acoustic neuritis;Acquired C1 inhibitor deficiency;Acquired epidermolysis bullosa;Acquired epileptic aphasia;Acute cutaneous lupus erythematosus;Acute disseminated encephalomyelitis;Acute encephalitis with refractory, repetitive partial seizures;Acute febrile neutrophilic dermatosis;Acute flaccid myelitis;Acute haemorrhagic leukoencephalitis;Acute haemorrhagic oedema of infancy;Acute kidney injury;Acute macular outer retinopathy;Acute motor axonal neuropathy;Acute motor-sensory axonal neuropathy;Acute myocardial infarction;Acute respiratory distress syndrome;Acute respiratory failure;Addison’s disease;Administration site thrombosis;Administration site vasculitis;Adrenal thrombosis;Adverse event following immunisation;Ageusia;Agranulocytosis;Air embolism;Alanine aminotransferase abnormal;Alanine aminotransferase increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic oedema;Alloimmune hepatitis;Alopecia areata;Alpers disease;Alveolar proteinosis;Ammonia abnormal;Ammonia increased;Amniotic cavity infection;Amygdalohippocampectomy;Amyloid arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic reaction;Anaphylactic shock;Anaphylactic transfusion reaction;Anaphylactoid reaction;Anaphylactoid shock;Anaphylactoid syndrome of pregnancy;Angioedema;Angiopathic neuropathy;Ankylosing spondylitis;Anosmia;Antiacetylcholine receptor antibody positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated peptide antibody positive;Anti-epithelial antibody positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody positive;AntiGAD antibody negative;Anti-GAD antibody positive;Anti-ganglioside antibody positive;Antigliadin antibody positive;Anti-glomerular basement membrane antibody positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2 antibody positive;Anti-insulin antibody increased;Anti-insulin antibody positive;Anti-insulin receptor antibody increased;Antiinsulin receptor antibody positive;Anti-interferon antibody negative;Anti-interferon antibody positive;Anti-islet cell antibody positive;Antimitochondrial antibody positive;Anti-muscle specific kinase antibody positive;Anti-myelin-associated glycoprotein antibodies positive;Anti-myelin-associated glycoprotein associated polyneuropathy;Antimyocardial antibody positive;Anti-neuronal antibody positive;Antineutrophil cytoplasmic antibody increased;Antineutrophil cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody increased;Antinuclear antibody positive;Antiphospholipid antibodies positive;Antiphospholipid syndrome;Anti-platelet antibody positive;Anti-prothrombin antibody positive;Antiribosomal P antibody positive;Anti-RNA polymerase III antibody positive;Anti-saccharomyces cerevisiae antibody test positive;Anti-sperm antibody positive;Anti-SRP antibody positive;Antisynthetase syndrome;Anti-thyroid antibody positive;Anti-transglutaminase antibody increased;Anti-VGCC antibody positive;AntiVGKC antibody positive;Anti-vimentin antibody positive;Antiviral prophylaxis;Antiviral treatment;Anti-zinc transporter 8 antibody positive;Aortic embolus;Aortic thrombosis;Aortitis;Aplasia pure red cell;Aplastic anaemia;Application site thrombosis;Application site vasculitis;Arrhythmia;Arterial bypass occlusion;Arterial bypass thrombosis;Arterial thrombosis;Arteriovenous fistula thrombosis;Arteriovenous graft site stenosis;Arteriovenous graft thrombosis;Arteritis;Arteritis Page 30 090177e196ea1800\Approved\Approved On: 30-A pr-2021 09:26 (GMT) FDA-CBER-2021-5683-0000083 BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports CONFIDENTIAL Page 2 coronary;Arthralgia;Arthritis;Arthritis enteropathic;Ascites;Aseptic cavernous sinus thrombosis;Aspartate aminotransferase abnormal;Aspartate aminotransferase increased;Aspartate-glutamate-transporter deficiency;AST to platelet ratio index increased;AST/ALT ratio abnormal;Asthma;Asymptomatic COVID19;Ataxia;Atheroembolism;Atonic seizures;Atrial thrombosis;Atrophic thyroiditis;Atypical benign partial epilepsy;Atypical pneumonia;Aura;Autoantibody positive;Autoimmune anaemia;Autoimmune aplastic anaemia;Autoimmune arthritis;Autoimmune blistering disease;Autoimmune cholangitis;Autoimmune colitis;Autoimmune demyelinating disease;Autoimmune dermatitis;Autoimmune disorder;Autoimmune encephalopathy;Autoimmune endocrine disorder;Autoimmune enteropathy;Autoimmune eye disorder;Autoimmune haemolytic anaemia;Autoimmune heparin-induced thrombocytopenia;Autoimmune hepatitis;Autoimmune hyperlipidaemia;Autoimmune hypothyroidism;Autoimmune inner ear disease;Autoimmune lung disease;Autoimmune lymphoproliferative syndrome;Autoimmune myocarditis;Autoimmune myositis;Autoimmune nephritis;Autoimmune neuropathy;Autoimmune neutropenia;Autoimmune pancreatitis;Autoimmune pancytopenia;Autoimmune pericarditis;Autoimmune retinopathy;Autoimmune thyroid disorder;Autoimmune thyroiditis;Autoimmune uveitis;Autoinflammation with infantile enterocolitis;Autoinflammatory disease;Automatism epileptic;Autonomic nervous system imbalance;Autonomic seizure;Axial spondyloarthritis;Axillary vein thrombosis;Axonal and demyelinating polyneuropathy;Axonal neuropathy;Bacterascites;Baltic myoclonic epilepsy;Band sensation;Basedow’s disease;Basilar artery thrombosis;Basophilopenia;B-cell aplasia;Behcet’s syndrome;Benign ethnic neutropenia;Benign familial neonatal convulsions;Benign familial pemphigus;Benign rolandic epilepsy;Beta-2 glycoprotein antibody positive;Bickerstaff’s encephalitis;Bile output abnormal;Bile output decreased;Biliary ascites;Bilirubin conjugated abnormal;Bilirubin conjugated increased;Bilirubin urine present;Biopsy liver abnormal;Biotinidase deficiency;Birdshot chorioretinopathy;Blood alkaline phosphatase abnormal;Blood alkaline phosphatase increased;Blood bilirubin abnormal;Blood bilirubin increased;Blood bilirubin unconjugated increased;Blood cholinesterase abnormal;Blood cholinesterase decreased;Blood pressure decreased;Blood pressure diastolic decreased;Blood pressure systolic decreased;Blue toe syndrome;Brachiocephalic vein thrombosis;Brain stem embolism;Brain stem thrombosis;Bromosulphthalein test abnormal;Bronchial oedema;Bronchitis;Bronchitis mycoplasmal;Bronchitis viral;Bronchopulmonary aspergillosis allergic;Bronchospasm;BuddChiari syndrome;Bulbar palsy;Butterfly rash;C1q nephropathy;Caesarean section;Calcium embolism;Capillaritis;Caplan’s syndrome;Cardiac amyloidosis;Cardiac arrest;Cardiac failure;Cardiac failure acute;Cardiac sarcoidosis;Cardiac ventricular thrombosis;Cardiogenic shock;Cardiolipin antibody positive;Cardiopulmonary failure;Cardio-respiratory arrest;Cardio-respiratory distress;Cardiovascular insufficiency;Carotid arterial embolus;Carotid artery thrombosis;Cataplexy;Catheter site thrombosis;Catheter site vasculitis;Cavernous sinus thrombosis;CDKL5 deficiency disorder;CEC syndrome;Cement embolism;Central nervous system lupus;Central nervous system vasculitis;Cerebellar artery thrombosis;Cerebellar embolism;Cerebral amyloid angiopathy;Cerebral arteritis;Cerebral artery embolism;Cerebral artery thrombosis;Cerebral gas embolism;Cerebral microembolism;Cerebral septic infarct;Cerebral thrombosis;Cerebral venous sinus thrombosis;Cerebral venous thrombosis;Cerebrospinal thrombotic Page 31 090177e196ea1800\Approved\Approved On: 30-A pr-2021 09:26 (GMT) FDA-CBER-2021-5683-0000084 BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports CONFIDENTIAL Page 3 tamponade;Cerebrovascular accident;Change in seizure presentation;Chest discomfort;ChildPugh-Turcotte score abnormal;Child-Pugh-Turcotte score increased;Chillblains;Choking;Choking sensation;Cholangitis sclerosing;Chronic autoimmune glomerulonephritis;Chronic cutaneous lupus erythematosus;Chronic fatigue syndrome;Chronic gastritis;Chronic inflammatory demyelinating polyradiculoneuropathy;Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids;Chronic recurrent multifocal osteomyelitis;Chronic respiratory failure;Chronic spontaneous urticaria;Circulatory collapse;Circumoral oedema;Circumoral swelling;Clinically isolated syndrome;Clonic convulsion;Coeliac disease;Cogan’s syndrome;Cold agglutinins positive;Cold type haemolytic anaemia;Colitis;Colitis erosive;Colitis herpes;Colitis microscopic;Colitis ulcerative;Collagen disorder;Collagen-vascular disease;Complement factor abnormal;Complement factor C1 decreased;Complement factor C2 decreased;Complement factor C3 decreased;Complement factor C4 decreased;Complement factor decreased;Computerised tomogram liver abnormal;Concentric sclerosis;Congenital anomaly;Congenital bilateral perisylvian syndrome;Congenital herpes simplex infection;Congenital myasthenic syndrome;Congenital varicella infection;Congestive hepatopathy;Convulsion in childhood;Convulsions local;Convulsive threshold lowered;Coombs positive haemolytic anaemia;Coronary artery disease;Coronary artery embolism;Coronary artery thrombosis;Coronary bypass thrombosis;Coronavirus infection;Coronavirus test;Coronavirus test negative;Coronavirus test positive;Corpus callosotomy;Cough;Cough variant asthma;COVID-19;COVID-19 immunisation;COVID-19 pneumonia;COVID-19 prophylaxis;COVID-19 treatment;Cranial nerve disorder;Cranial nerve palsies multiple;Cranial nerve paralysis;CREST syndrome;Crohn’s disease;Cryofibrinogenaemia;Cryoglobulinaemia;CSF oligoclonal band present;CSWS syndrome;Cutaneous amyloidosis;Cutaneous lupus erythematosus;Cutaneous sarcoidosis;Cutaneous vasculitis;Cyanosis;Cyclic neutropenia;Cystitis interstitial;Cytokine release syndrome;Cytokine storm;De novo purine synthesis inhibitors associated acute inflammatory syndrome;Death neonatal;Deep vein thrombosis;Deep vein thrombosis postoperative;Deficiency of bile secretion;Deja vu;Demyelinating polyneuropathy;Demyelination;Dermatitis;Dermatitis bullous;Dermatitis herpetiformis;Dermatomyositis;Device embolisation;Device related thrombosis;Diabetes mellitus;Diabetic ketoacidosis;Diabetic mastopathy;Dialysis amyloidosis;Dialysis membrane reaction;Diastolic hypotension;Diffuse vasculitis;Digital pitting scar;Disseminated intravascular coagulation;Disseminated intravascular coagulation in newborn;Disseminated neonatal herpes simplex;Disseminated varicella;Disseminated varicella zoster vaccine virus infection;Disseminated varicella zoster virus infection;DNA antibody positive;Double cortex syndrome;Double stranded DNA antibody positive;Dreamy state;Dressler’s syndrome;Drop attacks;Drug withdrawal convulsions;Dyspnoea;Early infantile epileptic encephalopathy with burst-suppression;Eclampsia;Eczema herpeticum;Embolia cutis medicamentosa;Embolic cerebellar infarction;Embolic cerebral infarction;Embolic pneumonia;Embolic stroke;Embolism;Embolism arterial;Embolism venous;Encephalitis;Encephalitis allergic;Encephalitis autoimmune;Encephalitis brain stem;Encephalitis haemorrhagic;Encephalitis periaxialis diffusa;Encephalitis post immunisation;Encephalomyelitis;Encephalopathy;Endocrine disorder;Endocrine ophthalmopathy;Endotracheal intubation;Enteritis;Enteritis leukopenic;Enterobacter pneumonia;Enterocolitis;Enteropathic spondylitis;Eosinopenia;Eosinophilic Page 32 090177e196ea1800\Approved\Approved On: 30-A pr-2021 09:26 (GMT) FDA-CBER-2021-5683-0000085 BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports CONFIDENTIAL Page 4 fasciitis;Eosinophilic granulomatosis with polyangiitis;Eosinophilic oesophagitis;Epidermolysis;Epilepsy;Epilepsy surgery;Epilepsy with myoclonic-atonic seizures;Epileptic aura;Epileptic psychosis;Erythema;Erythema induratum;Erythema multiforme;Erythema nodosum;Evans syndrome;Exanthema subitum;Expanded disability status scale score decreased;Expanded disability status scale score increased;Exposure to communicable disease;Exposure to SARS-CoV-2;Eye oedema;Eye pruritus;Eye swelling;Eyelid oedema;Face oedema;Facial paralysis;Facial paresis;Faciobrachial dystonic seizure;Fat embolism;Febrile convulsion;Febrile infection-related epilepsy syndrome;Febrile neutropenia;Felty’s syndrome;Femoral artery embolism;Fibrillary glomerulonephritis;Fibromyalgia;Flushing;Foaming at mouth;Focal cortical resection;Focal dyscognitive seizures;Foetal distress syndrome;Foetal placental thrombosis;Foetor hepaticus;Foreign body embolism;Frontal lobe epilepsy;Fulminant type 1 diabetes mellitus;Galactose elimination capacity test abnormal;Galactose elimination capacity test decreased;Gamma-glutamyltransferase abnormal;Gamma-glutamyltransferase increased;Gastritis herpes;Gastrointestinal amyloidosis;Gelastic seizure;Generalised onset non-motor seizure;Generalised tonic-clonic seizure;Genital herpes;Genital herpes simplex;Genital herpes zoster;Giant cell arteritis;Glomerulonephritis;Glomerulonephritis membranoproliferative;Glomerulonephritis membranous;Glomerulonephritis rapidly progressive;Glossopharyngeal nerve paralysis;Glucose transporter type 1 deficiency syndrome;Glutamate dehydrogenase increased;Glycocholic acid increased;GM2 gangliosidosis;Goodpasture’s syndrome;Graft thrombosis;Granulocytopenia;Granulocytopenia neonatal;Granulomatosis with polyangiitis;Granulomatous dermatitis;Grey matter heterotopia;Guanase increased;GuillainBarre syndrome;Haemolytic anaemia;Haemophagocytic lymphohistiocytosis;Haemorrhage;Haemorrhagic ascites;Haemorrhagic disorder;Haemorrhagic pneumonia;Haemorrhagic varicella syndrome;Haemorrhagic vasculitis;Hantavirus pulmonary infection;Hashimoto’s encephalopathy;Hashitoxicosis;Hemimegalencephaly;Henoch-Schonlein purpura;HenochSchonlein purpura nephritis;Hepaplastin abnormal;Hepaplastin decreased;Heparin-induced thrombocytopenia;Hepatic amyloidosis;Hepatic artery embolism;Hepatic artery flow decreased;Hepatic artery thrombosis;Hepatic enzyme abnormal;Hepatic enzyme decreased;Hepatic enzyme increased;Hepatic fibrosis marker abnormal;Hepatic fibrosis marker increased;Hepatic function abnormal;Hepatic hydrothorax;Hepatic hypertrophy;Hepatic hypoperfusion;Hepatic lymphocytic infiltration;Hepatic mass;Hepatic pain;Hepatic sequestration;Hepatic vascular resistance increased;Hepatic vascular thrombosis;Hepatic vein embolism;Hepatic vein thrombosis;Hepatic venous pressure gradient abnormal;Hepatic venous pressure gradient increased;Hepatitis;Hepatobiliary scan abnormal;Hepatomegaly;Hepatosplenomegaly;Hereditary angioedema with C1 esterase inhibitor deficiency;Herpes dermatitis;Herpes gestationis;Herpes oesophagitis;Herpes ophthalmic;Herpes pharyngitis;Herpes sepsis;Herpes simplex;Herpes simplex cervicitis;Herpes simplex colitis;Herpes simplex encephalitis;Herpes simplex gastritis;Herpes simplex hepatitis;Herpes simplex meningitis;Herpes simplex meningoencephalitis;Herpes simplex meningomyelitis;Herpes simplex necrotising retinopathy;Herpes simplex oesophagitis;Herpes simplex otitis externa;Herpes simplex pharyngitis;Herpes simplex pneumonia;Herpes simplex reactivation;Herpes simplex sepsis;Herpes simplex viraemia;Herpes simplex virus conjunctivitis neonatal;Herpes simplex visceral;Herpes virus Page 33 090177e196ea1800\Approved\Approved On: 30-A pr-2021 09:26 (GMT) FDA-CBER-2021-5683-0000086 BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports CONFIDENTIAL Page 5 infection;Herpes zoster;Herpes zoster cutaneous disseminated;Herpes zoster infection neurological;Herpes zoster meningitis;Herpes zoster meningoencephalitis;Herpes zoster meningomyelitis;Herpes zoster meningoradiculitis;Herpes zoster necrotising retinopathy;Herpes zoster oticus;Herpes zoster pharyngitis;Herpes zoster reactivation;Herpetic radiculopathy;Histone antibody positive;Hoigne’s syndrome;Human herpesvirus 6 encephalitis;Human herpesvirus 6 infection;Human herpesvirus 6 infection reactivation;Human herpesvirus 7 infection;Human herpesvirus 8 infection;Hyperammonaemia;Hyperbilirubinaemia;Hypercholia;Hypergammaglobulinaemia benign monoclonal;Hyperglycaemic seizure;Hypersensitivity;Hypersensitivity vasculitis;Hyperthyroidism;Hypertransaminasaemia;Hyperventilation;Hypoalbuminaemia;H ypocalcaemic seizure;Hypogammaglobulinaemia;Hypoglossal nerve paralysis;Hypoglossal nerve paresis;Hypoglycaemic seizure;Hyponatraemic seizure;Hypotension;Hypotensive crisis;Hypothenar hammer syndrome;Hypothyroidism;Hypoxia;Idiopathic CD4 lymphocytopenia;Idiopathic generalised epilepsy;Idiopathic interstitial pneumonia;Idiopathic neutropenia;Idiopathic pulmonary fibrosis;IgA nephropathy;IgM nephropathy;IIIrd nerve paralysis;IIIrd nerve paresis;Iliac artery embolism;Immune thrombocytopenia;Immunemediated adverse reaction;Immune-mediated cholangitis;Immune-mediated cholestasis;Immune-mediated cytopenia;Immune-mediated encephalitis;Immune-mediated encephalopathy;Immune-mediated endocrinopathy;Immune-mediated enterocolitis;Immunemediated gastritis;Immune-mediated hepatic disorder;Immune-mediated hepatitis;Immunemediated hyperthyroidism;Immune-mediated hypothyroidism;Immune-mediated myocarditis;Immune-mediated myositis;Immune-mediated nephritis;Immune-mediated neuropathy;Immune-mediated pancreatitis;Immune-mediated pneumonitis;Immune-mediated renal disorder;Immune-mediated thyroiditis;Immune-mediated uveitis;Immunoglobulin G4 related disease;Immunoglobulins abnormal;Implant site thrombosis;Inclusion body myositis;Infantile genetic agranulocytosis;Infantile spasms;Infected vasculitis;Infective thrombosis;Inflammation;Inflammatory bowel disease;Infusion site thrombosis;Infusion site vasculitis;Injection site thrombosis;Injection site urticaria;Injection site vasculitis;Instillation site thrombosis;Insulin autoimmune syndrome;Interstitial granulomatous dermatitis;Interstitial lung disease;Intracardiac mass;Intracardiac thrombus;Intracranial pressure increased;Intrapericardial thrombosis;Intrinsic factor antibody abnormal;Intrinsic factor antibody positive;IPEX syndrome;Irregular breathing;IRVAN syndrome;IVth nerve paralysis;IVth nerve paresis;JC polyomavirus test positive;JC virus CSF test positive;Jeavons syndrome;Jugular vein embolism;Jugular vein thrombosis;Juvenile idiopathic arthritis;Juvenile myoclonic epilepsy;Juvenile polymyositis;Juvenile psoriatic arthritis;Juvenile spondyloarthritis;Kaposi sarcoma inflammatory cytokine syndrome;Kawasaki’s disease;Kayser-Fleischer ring;Keratoderma blenorrhagica;Ketosisprone diabetes mellitus;Kounis syndrome;Lafora’s myoclonic epilepsy;Lambl’s excrescences;Laryngeal dyspnoea;Laryngeal oedema;Laryngeal rheumatoid arthritis;Laryngospasm;Laryngotracheal oedema;Latent autoimmune diabetes in adults;LE cells present;Lemierre syndrome;Lennox-Gastaut syndrome;Leucine aminopeptidase increased;Leukoencephalomyelitis;Leukoencephalopathy;Leukopenia;Leukopenia neonatal;Lewis-Sumner syndrome;Lhermitte’s sign;Lichen planopilaris;Lichen planus;Lichen sclerosus;Limbic encephalitis;Linear IgA disease;Lip oedema;Lip swelling;Liver function test abnormal;Liver function test decreased;Liver function test increased;Liver induration;Liver injury;Liver iron concentration abnormal;Liver iron concentration Page 34 090177e196ea1800\Approved\Approved On: 30-A pr-2021 09:26 (GMT) FDA-CBER-2021-5683-0000087 BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports CONFIDENTIAL Page 6 increased;Liver opacity;Liver palpable;Liver sarcoidosis;Liver scan abnormal;Liver tenderness;Low birth weight baby;Lower respiratory tract herpes infection;Lower respiratory tract infection;Lower respiratory tract infection viral;Lung abscess;Lupoid hepatic cirrhosis;Lupus cystitis;Lupus encephalitis;Lupus endocarditis;Lupus enteritis;Lupus hepatitis;Lupus myocarditis;Lupus myositis;Lupus nephritis;Lupus pancreatitis;Lupus pleurisy;Lupus pneumonitis;Lupus vasculitis;Lupus-like syndrome;Lymphocytic hypophysitis;Lymphocytopenia neonatal;Lymphopenia;MAGIC syndrome;Magnetic resonance imaging liver abnormal;Magnetic resonance proton density fat fraction measurement;Mahler sign;Manufacturing laboratory analytical testing issue;Manufacturing materials issue;Manufacturing production issue;Marburg’s variant multiple sclerosis;Marchiafava-Bignami disease;Marine Lenhart syndrome;Mastocytic enterocolitis;Maternal exposure during pregnancy;Medical device site thrombosis;Medical device site vasculitis;MELAS syndrome;Meningitis;Meningitis aseptic;Meningitis herpes;Meningoencephalitis herpes simplex neonatal;Meningoencephalitis herpetic;Meningomyelitis herpes;MERS-CoV test;MERS-CoV test negative;MERS-CoV test positive;Mesangioproliferative glomerulonephritis;Mesenteric artery embolism;Mesenteric artery thrombosis;Mesenteric vein thrombosis;Metapneumovirus infection;Metastatic cutaneous Crohn’s disease;Metastatic pulmonary embolism;Microangiopathy;Microembolism;Microscopic polyangiitis;Middle East respiratory syndrome;Migraine-triggered seizure;Miliary pneumonia;Miller Fisher syndrome;Mitochondrial aspartate aminotransferase increased;Mixed connective tissue disease;Model for end stage liver disease score abnormal;Model for end stage liver disease score increased;Molar ratio of total branched-chain amino acid to tyrosine;Molybdenum cofactor deficiency;Monocytopenia;Mononeuritis;Mononeuropathy multiplex;Morphoea;Morvan syndrome;Mouth swelling;Moyamoya disease;Multifocal motor neuropathy;Multiple organ dysfunction syndrome;Multiple sclerosis;Multiple sclerosis relapse;Multiple sclerosis relapse prophylaxis;Multiple subpial transection;Multisystem inflammatory syndrome in children;Muscular sarcoidosis;Myasthenia gravis;Myasthenia gravis crisis;Myasthenia gravis neonatal;Myasthenic syndrome;Myelitis;Myelitis transverse;Myocardial infarction;Myocarditis;Myocarditis post infection;Myoclonic epilepsy;Myoclonic epilepsy and ragged-red fibres;Myokymia;Myositis;Narcolepsy;Nasal herpes;Nasal obstruction;Necrotising herpetic retinopathy;Neonatal Crohn’s disease;Neonatal epileptic seizure;Neonatal lupus erythematosus;Neonatal mucocutaneous herpes simplex;Neonatal pneumonia;Neonatal seizure;Nephritis;Nephrogenic systemic fibrosis;Neuralgic amyotrophy;Neuritis;Neuritis cranial;Neuromyelitis optica pseudo relapse;Neuromyelitis optica spectrum disorder;Neuromyotonia;Neuronal neuropathy;Neuropathy peripheral;Neuropathy, ataxia, retinitis pigmentosa syndrome;Neuropsychiatric lupus;Neurosarcoidosis;Neutropenia;Neutropenia neonatal;Neutropenic colitis;Neutropenic infection;Neutropenic sepsis;Nodular rash;Nodular vasculitis;Noninfectious myelitis;Noninfective encephalitis;Noninfective encephalomyelitis;Noninfective oophoritis;Obstetrical pulmonary embolism;Occupational exposure to communicable disease;Occupational exposure to SARS-CoV-2;Ocular hyperaemia;Ocular myasthenia;Ocular pemphigoid;Ocular sarcoidosis;Ocular vasculitis;Oculofacial paralysis;Oedema;Oedema blister;Oedema due to hepatic disease;Oedema mouth;Oesophageal achalasia;Ophthalmic artery thrombosis;Ophthalmic herpes simplex;Ophthalmic herpes zoster;Ophthalmic vein thrombosis;Optic neuritis;Optic Page 35 090177e196ea1800\Approved\Approved On: 30-A pr-2021 09:26 (GMT) FDA-CBER-2021-5683-0000088 BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports CONFIDENTIAL Page 7 neuropathy;Optic perineuritis;Oral herpes;Oral lichen planus;Oropharyngeal oedema;Oropharyngeal spasm;Oropharyngeal swelling;Osmotic demyelination syndrome;Ovarian vein thrombosis;Overlap syndrome;Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection;Paget-Schroetter syndrome;Palindromic rheumatism;Palisaded neutrophilic granulomatous dermatitis;Palmoplantar keratoderma;Palpable purpura;Pancreatitis;Panencephalitis;Papillophlebitis;Paracancerous pneumonia;Paradoxical embolism;Parainfluenzae viral laryngotracheobronchitis;Paraneoplastic dermatomyositis;Paraneoplastic pemphigus;Paraneoplastic thrombosis;Paresis cranial nerve;Parietal cell antibody positive;Paroxysmal nocturnal haemoglobinuria;Partial seizures;Partial seizures with secondary generalisation;Patient isolation;Pelvic venous thrombosis;Pemphigoid;Pemphigus;Penile vein thrombosis;Pericarditis;Pericarditis lupus;Perihepatic discomfort;Periorbital oedema;Periorbital swelling;Peripheral artery thrombosis;Peripheral embolism;Peripheral ischaemia;Peripheral vein thrombus extension;Periportal oedema;Peritoneal fluid protein abnormal;Peritoneal fluid protein decreased;Peritoneal fluid protein increased;Peritonitis lupus;Pernicious anaemia;Petit mal epilepsy;Pharyngeal oedema;Pharyngeal swelling;Pityriasis lichenoides et varioliformis acuta;Placenta praevia;Pleuroparenchymal fibroelastosis;Pneumobilia;Pneumonia;Pneumonia adenoviral;Pneumonia cytomegaloviral;Pneumonia herpes viral;Pneumonia influenzal;Pneumonia measles;Pneumonia mycoplasmal;Pneumonia necrotising;Pneumonia parainfluenzae viral;Pneumonia respiratory syncytial viral;Pneumonia viral;POEMS syndrome;Polyarteritis nodosa;Polyarthritis;Polychondritis;Polyglandular autoimmune syndrome type I;Polyglandular autoimmune syndrome type II;Polyglandular autoimmune syndrome type III;Polyglandular disorder;Polymicrogyria;Polymyalgia rheumatica;Polymyositis;Polyneuropathy;Polyneuropathy idiopathic progressive;Portal pyaemia;Portal vein embolism;Portal vein flow decreased;Portal vein pressure increased;Portal vein thrombosis;Portosplenomesenteric venous thrombosis;Post procedural hypotension;Post procedural pneumonia;Post procedural pulmonary embolism;Post stroke epilepsy;Post stroke seizure;Post thrombotic retinopathy;Post thrombotic syndrome;Post viral fatigue syndrome;Postictal headache;Postictal paralysis;Postictal psychosis;Postictal state;Postoperative respiratory distress;Postoperative respiratory failure;Postoperative thrombosis;Postpartum thrombosis;Postpartum venous thrombosis;Postpericardiotomy syndrome;Post-traumatic epilepsy;Postural orthostatic tachycardia syndrome;Precerebral artery thrombosis;Pre-eclampsia;Preictal state;Premature labour;Premature menopause;Primary amyloidosis;Primary biliary cholangitis;Primary progressive multiple sclerosis;Procedural shock;Proctitis herpes;Proctitis ulcerative;Product availability issue;Product distribution issue;Product supply issue;Progressive facial hemiatrophy;Progressive multifocal leukoencephalopathy;Progressive multiple sclerosis;Progressive relapsing multiple sclerosis;Prosthetic cardiac valve thrombosis;Pruritus;Pruritus allergic;Pseudovasculitis;Psoriasis;Psoriatic arthropathy;Pulmonary amyloidosis;Pulmonary artery thrombosis;Pulmonary embolism;Pulmonary fibrosis;Pulmonary haemorrhage;Pulmonary microemboli;Pulmonary oil microembolism;Pulmonary renal syndrome;Pulmonary sarcoidosis;Pulmonary sepsis;Pulmonary thrombosis;Pulmonary tumour thrombotic microangiopathy;Pulmonary vasculitis;Pulmonary veno-occlusive disease;Pulmonary venous thrombosis;Pyoderma gangrenosum;Pyostomatitis vegetans;Pyrexia;Quarantine;Radiation leukopenia;Radiculitis Page 36 090177e196ea1800\Approved\Approved On: 30-A pr-2021 09:26 (GMT) FDA-CBER-2021-5683-0000089 BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports CONFIDENTIAL Page 8 brachial;Radiologically isolated syndrome;Rash;Rash erythematous;Rash pruritic;Rasmussen encephalitis;Raynaud’s phenomenon;Reactive capillary endothelial proliferation;Relapsing multiple sclerosis;Relapsing-remitting multiple sclerosis;Renal amyloidosis;Renal arteritis;Renal artery thrombosis;Renal embolism;Renal failure;Renal vascular thrombosis;Renal vasculitis;Renal vein embolism;Renal vein thrombosis;Respiratory arrest;Respiratory disorder;Respiratory distress;Respiratory failure;Respiratory paralysis;Respiratory syncytial virus bronchiolitis;Respiratory syncytial virus bronchitis;Retinal artery embolism;Retinal artery occlusion;Retinal artery thrombosis;Retinal vascular thrombosis;Retinal vasculitis;Retinal vein occlusion;Retinal vein thrombosis;Retinol binding protein decreased;Retinopathy;Retrograde portal vein flow;Retroperitoneal fibrosis;Reversible airways obstruction;Reynold’s syndrome;Rheumatic brain disease;Rheumatic disorder;Rheumatoid arthritis;Rheumatoid factor increased;Rheumatoid factor positive;Rheumatoid factor quantitative increased;Rheumatoid lung;Rheumatoid neutrophilic dermatosis;Rheumatoid nodule;Rheumatoid nodule removal;Rheumatoid scleritis;Rheumatoid vasculitis;Saccadic eye movement;SAPHO syndrome;Sarcoidosis;SARS-CoV-1 test;SARS-CoV-1 test negative;SARS-CoV-1 test positive;SARS-CoV-2 antibody test;SARS-CoV-2 antibody test negative;SARS-CoV-2 antibody test positive;SARS-CoV-2 carrier;SARS-CoV-2 sepsis;SARS-CoV-2 test;SARSCoV-2 test false negative;SARS-CoV-2 test false positive;SARS-CoV-2 test negative;SARSCoV-2 test positive;SARS-CoV-2 viraemia;Satoyoshi syndrome;Schizencephaly;Scleritis;Sclerodactylia;Scleroderma;Scleroderma associated digital ulcer;Scleroderma renal crisis;Scleroderma-like reaction;Secondary amyloidosis;Secondary cerebellar degeneration;Secondary progressive multiple sclerosis;Segmented hyalinising vasculitis;Seizure;Seizure anoxic;Seizure cluster;Seizure like phenomena;Seizure prophylaxis;Sensation of foreign body;Septic embolus;Septic pulmonary embolism;Severe acute respiratory syndrome;Severe myoclonic epilepsy of infancy;Shock;Shock symptom;Shrinking lung syndrome;Shunt thrombosis;Silent thyroiditis;Simple partial seizures;Sjogren’s syndrome;Skin swelling;SLE arthritis;Smooth muscle antibody positive;Sneezing;Spinal artery embolism;Spinal artery thrombosis;Splenic artery thrombosis;Splenic embolism;Splenic thrombosis;Splenic vein thrombosis;Spondylitis;Spondyloarthropathy;Spontaneous heparin-induced thrombocytopenia syndrome;Status epilepticus;Stevens-Johnson syndrome;Stiff leg syndrome;Stiff person syndrome;Stillbirth;Still’s disease;Stoma site thrombosis;Stoma site vasculitis;Stress cardiomyopathy;Stridor;Subacute cutaneous lupus erythematosus;Subacute endocarditis;Subacute inflammatory demyelinating polyneuropathy;Subclavian artery embolism;Subclavian artery thrombosis;Subclavian vein thrombosis;Sudden unexplained death in epilepsy;Superior sagittal sinus thrombosis;Susac’s syndrome;Suspected COVID19;Swelling;Swelling face;Swelling of eyelid;Swollen tongue;Sympathetic ophthalmia;Systemic lupus erythematosus;Systemic lupus erythematosus disease activity index abnormal;Systemic lupus erythematosus disease activity index decreased;Systemic lupus erythematosus disease activity index increased;Systemic lupus erythematosus rash;Systemic scleroderma;Systemic sclerosis pulmonary;Tachycardia;Tachypnoea;Takayasu’s arteritis;Temporal lobe epilepsy;Terminal ileitis;Testicular autoimmunity;Throat tightness;Thromboangiitis obliterans;Thrombocytopenia;Thrombocytopenic purpura;Thrombophlebitis;Thrombophlebitis migrans;Thrombophlebitis Page 37 090177e196ea1800\Approved\Approved On: 30-A pr-2021 09:26 (GMT) FDA-CBER-2021-5683-0000090 BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports CONFIDENTIAL Page 9 neonatal;Thrombophlebitis septic;Thrombophlebitis superficial;Thromboplastin antibody positive;Thrombosis;Thrombosis corpora cavernosa;Thrombosis in device;Thrombosis mesenteric vessel;Thrombotic cerebral infarction;Thrombotic microangiopathy;Thrombotic stroke;Thrombotic thrombocytopenic purpura;Thyroid disorder;Thyroid stimulating immunoglobulin increased;Thyroiditis;Tongue amyloidosis;Tongue biting;Tongue oedema;Tonic clonic movements;Tonic convulsion;Tonic posturing;Topectomy;Total bile acids increased;Toxic epidermal necrolysis;Toxic leukoencephalopathy;Toxic oil syndrome;Tracheal obstruction;Tracheal oedema;Tracheobronchitis;Tracheobronchitis mycoplasmal;Tracheobronchitis viral;Transaminases abnormal;Transaminases increased;Transfusion-related alloimmune neutropenia;Transient epileptic amnesia;Transverse sinus thrombosis;Trigeminal nerve paresis;Trigeminal neuralgia;Trigeminal palsy;Truncus coeliacus thrombosis;Tuberous sclerosis complex;Tubulointerstitial nephritis and uveitis syndrome;Tumefactive multiple sclerosis;Tumour embolism;Tumour thrombosis;Type 1 diabetes mellitus;Type I hypersensitivity;Type III immune complex mediated reaction;Uhthoff’s phenomenon;Ulcerative keratitis;Ultrasound liver abnormal;Umbilical cord thrombosis;Uncinate fits;Undifferentiated connective tissue disease;Upper airway obstruction;Urine bilirubin increased;Urobilinogen urine decreased;Urobilinogen urine increased;Urticaria;Urticaria papular;Urticarial vasculitis;Uterine rupture;Uveitis;Vaccination site thrombosis;Vaccination site vasculitis;Vagus nerve paralysis;Varicella;Varicella keratitis;Varicella post vaccine;Varicella zoster gastritis;Varicella zoster oesophagitis;Varicella zoster pneumonia;Varicella zoster sepsis;Varicella zoster virus infection;Vasa praevia;Vascular graft thrombosis;Vascular pseudoaneurysm thrombosis;Vascular purpura;Vascular stent thrombosis;Vasculitic rash;Vasculitic ulcer;Vasculitis;Vasculitis gastrointestinal;Vasculitis necrotising;Vena cava embolism;Vena cava thrombosis;Venous intravasation;Venous recanalisation;Venous thrombosis;Venous thrombosis in pregnancy;Venous thrombosis limb;Venous thrombosis neonatal;Vertebral artery thrombosis;Vessel puncture site thrombosis;Visceral venous thrombosis;VIth nerve paralysis;VIth nerve paresis;Vitiligo;Vocal cord paralysis;Vocal cord paresis;Vogt-Koyanagi-Harada disease;Warm type haemolytic anaemia;Wheezing;White nipple sign;XIth nerve paralysis;X-ray hepatobiliary abnormal;Young’s syndrome;Zika virus associated Guillain Barre syndrome.

trackback
2 months ago

[…] Canadian Researchers Find Carbon Nanotech and Thulium in Moderna and Pfizer Covid Injections: https://expose-news.com/2022/05/27/carbon-nanotech-and-thulium-in-covid-injections/ […]

trackback
2 months ago

[…] 2022-05-28 04:01:00, Na het bekijken van elektronenmicroscoopbeelden van elementen in de Covid Pfizer en Moderna injecties, heeft Dr. Daniel Nagase onthuld dat, vreemd genoeg, de inhoud van de Pfizer en Moderna “vaccins” geen tekenen vertonen van biologisch materiaal, met inbegrip van mRNA of DNA, bericht Expose-news.com. […]

trackback
2 months ago

[…] Канадские исследователи обнаружили углеродные нанотехнологии и тулий в инъекциях Moderna и Pfizer Covid – https://expose-news.com/2022/05/27/carbon-nanotech-and-thulium-in-covid-injections/ […]

trackback
2 months ago

[…] Kanadische Forscher finden Carbon Nanotech und Thulium in Covid-Injektionen von Moderna und Pfizer: https://expose-news.com/2022/05/27/carbon-nanotech-and-thulium-in-covid-injections/ […]

trackback
2 months ago

[…] «Kanadyjscy badacze znaleźli w preparatach Moderna i Pfizer nanotechnologię węglową oraz tul» https://expose-news.com/2022/05/27/carbon-nanotech-and-thulium-in-covid-injections/ […]

trackback
2 months ago

[…] – Canadian Researchers Find Carbon Nanotech and Thulium in Moderna and Pfizer Covid Injections […]

trackback
2 months ago

[…] News) A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] News) A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] News)A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] News) A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] News) A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] News) A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] News) A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] News) A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] News) A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] Ein kanadischer Forscher und Notarzt hat kürzlich die Covid-19-Impfstoffe von Pfizer und Moderna unter die Lupe genommen, um zu sehen, woraus sie bestehen. […]

trackback
2 months ago

[…] Un ricercatore canadese e medico di emergenza ha recentemente testato i vaccini Pfizer e Moderna Covid-19 esaminati per vedere di che pasta sono fatti. […]

trackback
2 months ago

[…] Ein kanadischer Forscher und Notarzt hat kürzlich die Covid-19-Impfstoffe von Pfizer und Moderna unter die Lupe genommen, um zu sehen, woraus sie bestehen. […]

trackback
2 months ago

[…] Ein kanadischer Forscher und Notarzt hat kürzlich die Covid-19-Impfstoffe von Pfizer und Moderna unter die Lupe genommen, um zu sehen, woraus sie bestehen. […]

trackback
2 months ago

[…] Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] A Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

MONGO JERRY
MONGO JERRY
2 months ago

Could these “strands” be related to the long stringy blood clots as reported by some morticians??

trackback
2 months ago

[…] Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] Canadian researcher and ER doctor recently put the Pfizer and Moderna covid-19 vaccines under the microscope to see what they are made of. The electron microscope images show no sign of biological material, not DNA nor the glorified mRNA […]

trackback
2 months ago

[…] Electron microscope images show carbon nanotech, aluminum, thulium in Pfizer and Moderna’s covid-19 vaccines May 27, 2022 by Rhoda Wilson, Source […]

trackback
1 month ago

[…] de Urgencias recientemente puso bajo el microscopio las vacunas covid-19 de Pfizer y Moderna para ver de qué están hechas . Las imágenes del microscopio electrónico no muestran signos de material biológico, ni ADN, ni […]